RPG Life Sciences looks for larger API assets after acquisitions
In short
RPG Life Sciences is looking for bigger API businesses after spending ₹215 crore on acquisitions. The company says it still has more than ₹500 crore to use.
It wants assets that add special chemistry, regulatory access and export strength. The source does not say which businesses it is eyeing or when any deal could happen.
What the reporting says
RPG Life Sciences is scouting for larger API assets after ₹215 crore in acquisitions, according to the available summary. The company says it has more than ₹500 crore of capital available and is evaluating businesses that can add differentiated chemistry, regulatory access and export capabilities. The target names, deal timing and valuation are not stated.
Why it matters
RPG Life Sciences is reported to be searching for larger API assets after ₹215 crore of acquisitions. The company says it has more than ₹500 crore available and is assessing businesses that could add differentiated chemistry, regulatory access and export capabilities. That suggests further expansion in the pharma supply chain, but the source does not identify targets or deal terms.